skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial

Rosenstock, Julio ; Cheng, Alice ; Ritzel, Robert ; Bosnyak, Zsolt ; Devisme, Christine ; Cali, Anna M G ; Sieber, Jochen ; Stella, Peter ; Wang, Xiangling ; Frías, Juan P ; Roussel, Ronan ; Bolli, Geremia B

Diabetes care, 2018-10, Vol.41 (10), p.2147-2154 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
2
Semaphorin4D Induces Inhibitory Synapse Formation by Rapid Stabilization of Presynaptic Boutons via MET Coactivation
Semaphorin4D Induces Inhibitory Synapse Formation by Rapid Stabilization of Presynaptic Boutons via MET Coactivation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Semaphorin4D Induces Inhibitory Synapse Formation by Rapid Stabilization of Presynaptic Boutons via MET Coactivation

Frias, Cátia P ; Liang, Jian ; Bresser, Tom ; Scheefhals, Lisa ; van Kesteren, Matthijs ; van Dorland, René ; Hu, Hai Yin ; Bodzeta, Anna ; van Bergen En Henegouwen, Paul M P ; Hoogenraad, Casper C ; Wierenga, Corette J

The Journal of neuroscience, 2019-05, Vol.39 (22), p.4221-4237 [Periódico revisado por pares]

United States: Society for Neuroscience

Texto completo disponível

Citações Citado por
3
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

Blevins, Thomas ; Zhang, Qianyi ; Frias, Juan P ; Jinnouchi, Hideaki ; Chang, Annette M

Diabetes care, 2020-12, Vol.43 (12), p.2991-2998 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
4
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Frias, Juan P ; Bonora, Enzo ; Nevarez Ruiz, Luis ; Li, Ying G ; Yu, Zhuoxin ; Milicevic, Zvonko ; Malik, Raleigh ; Bethel, M Angelyn ; Cox, David A

Diabetes care, 2021-03, Vol.44 (3), p.765-773 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
5
806-P: Once Weekly (QW) Basal Insulin Fc (BIF) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in Three Patient Populations Studied during Phase 2—Clinical Insights from CGM Assessments
806-P: Once Weekly (QW) Basal Insulin Fc (BIF) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in Three Patient Populations Studied during Phase 2—Clinical Insights from CGM Assessments
Material Type:
Artigo 		Adicionar ao Meu Espaço

806-P: Once Weekly (QW) Basal Insulin Fc (BIF) and Daily Degludec (DEG) Achieve Comparable Glycemic Control in Three Patient Populations Studied during Phase 2—Clinical Insights from CGM Assessments

KAZDA, CHRISTOF M. ; BUE-VALLESKEY, JULIANA M. ; ZHANG, QIANYI ; HAUPT, AXEL ; FRIAS, JUAN P. ; DAHL, DOMINIK

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
6
788-P: Predictors of Achieving Target HbA1c <7% in People with Type 2 Diabetes Advancing Treatment with iGlarLixi
788-P: Predictors of Achieving Target HbA1c <7% in People with Type 2 Diabetes Advancing Treatment with iGlarLixi
Material Type:
Artigo 		Adicionar ao Meu Espaço

788-P: Predictors of Achieving Target HbA1c <7% in People with Type 2 Diabetes Advancing Treatment with iGlarLixi

CHENG, ALICE Y. ; FRIAS, JUAN P. ; GUJA, CRISTIAN ; LAUAND, FELIPE ; MELAS-MELT, LYDIE ; ALVAREZ, AGUSTINA ; SOUHAMI, ELISABETH ; ROSENSTOCK, JULIO

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
7
799-P: Predictors of Glycemic Control by Derived Time in Range for People with Type 2 Diabetes Advancing with iGlarLixi&#8212;A Pooled Analysis
799-P: Predictors of Glycemic Control by Derived Time in Range for People with Type 2 Diabetes Advancing with iGlarLixi&#8212;A Pooled Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

799-P: Predictors of Glycemic Control by Derived Time in Range for People with Type 2 Diabetes Advancing with iGlarLixi—A Pooled Analysis

HRAMIAK, IRENE ; FRIAS, JUAN P. ; AYDIN, HASAN ; LAUAND, FELIPE ; MELAS-MELT, LYDIE ; SOUHAMI, ELISABETH ; HALUZIK, MARTIN ; ROSENSTOCK, JULIO

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
8
811-P: Initiation of Once-Weekly (QW) Basal Insulin Fc (BIF) in Three Patient Populations in Phase 2 Studies Using a One-Time Loading Dose (LD) Minimizes Transient Hyperglycemia and Is Not Associated with Excess Hypoglycemia Risk vs. Degludec
811-P: Initiation of Once-Weekly (QW) Basal Insulin Fc (BIF) in Three Patient Populations in Phase 2 Studies Using a One-Time Loading Dose (LD) Minimizes Transient Hyperglycemia and Is Not Associated with Excess Hypoglycemia Risk vs. Degludec
Material Type:
Artigo 		Adicionar ao Meu Espaço

811-P: Initiation of Once-Weekly (QW) Basal Insulin Fc (BIF) in Three Patient Populations in Phase 2 Studies Using a One-Time Loading Dose (LD) Minimizes Transient Hyperglycemia and Is Not Associated with Excess Hypoglycemia Risk vs. Degludec

BUE-VALLESKEY, JULIANA M. ; KAZDA, CHRISTOF M. ; ZHANG, QIANYI ; HAUPT, AXEL ; DAHL, DOMINIK ; FRIAS, JUAN P.

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
9
800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes&#8212;Patient-Level Exploratory Analyses of the LixiLan-L Trial
800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes&#8212;Patient-Level Exploratory Analyses of the LixiLan-L Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

800-P: Predictors of HbA1c and dTIR Responses with iGlarLixi in Type 2 Diabetes—Patient-Level Exploratory Analyses of the LixiLan-L Trial

HALUZIK, MARTIN ; FRIAS, JUAN P. ; CHENG, ALICE Y. ; AL-SOFIANI, MOHAMMED ; LAUAND, FELIPE ; MELAS-MELT, LYDIE ; SOUHAMI, ELISABETH ; ROSENSTOCK, JULIO

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
10
1043-P: Uncovering Root Causes Contributing to Persistent Gaps in Glycemic Control and Effective Weight Management in Patients with Type 2 Diabetes and Obesity
1043-P: Uncovering Root Causes Contributing to Persistent Gaps in Glycemic Control and Effective Weight Management in Patients with Type 2 Diabetes and Obesity
Material Type:
Artigo 		Adicionar ao Meu Espaço

1043-P: Uncovering Root Causes Contributing to Persistent Gaps in Glycemic Control and Effective Weight Management in Patients with Type 2 Diabetes and Obesity

ZYBOROWICZ, EMILY ; HEGGEN, CHERILYN ; RODRIGUEZ, MELISSA A. ; CARTER, JEFFREY D. ; FRIAS, JUAN P.

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Periódico revisado por pares]

New York: American Diabetes Association

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (122)

Data de Publicação 

De até
Refinar
  1. Antes de1999  (11)
  2. 1999Até2003  (12)
  3. 2004Até2010  (14)
  4. 2011Até2016  (15)
  5. Após 2016  (72)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (14)
  2. Russo  (1)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.